Clinical Trials Browser

Neoplasm, Residual × niraparib × 1 year × Clear all

NCT03945721 2025-09-29

UNITY

Phase 1 Active not recruiting

Breast Neoplasms, Neoplasm, Residual, Triple Negative Breast Neoplasms